Skip to main content
. 2002 Aug 19;99(18):11813–11818. doi: 10.1073/pnas.142417699

Figure 4.

Figure 4

Analysis of cross-stimulation and cross-recognition of NY-ESO-1 peptides S9C, S11L, and L9L. ELISPOT with CD8+ T cells from vaccinated patient ES-E03 presensitized with the different NY-ESO-1 peptides and tested at day 9 against T2 cells pulsed with S9C (vertical stripes), S11L (solid), L9L (horizontal stripes), or without peptide (open).